A detailed history of Superstring Capital Management LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 740,294 shares of NKTX stock, worth $1.92 Million. This represents 2.93% of its overall portfolio holdings.

Number of Shares
740,294
Previous 875,999 15.49%
Holding current value
$1.92 Million
Previous $5.18 Billion 35.37%
% of portfolio
2.93%
Previous 6.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.52 - $8.0 $613,386 - $1.09 Million
-135,705 Reduced 15.49%
740,294 $3.35 Billion
Q2 2024

Aug 14, 2024

SELL
$5.27 - $10.82 $1.65 Million - $3.39 Million
-313,194 Reduced 26.34%
875,999 $5.18 Billion
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $4.71 Million - $13.2 Million
841,812 Added 242.33%
1,189,193 $12.9 Billion
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $455,069 - $2.29 Million
347,381 New
347,381 $2.29 Billion

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $126M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.